TotalMarketCap

Structure Therapeutics

GPCRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.355 B

$19.00 -6.68%

Close of 6 Nov 2026

As of 6 Nov 2026, Structure Therapeutics (GPCR) has a market capitalization of $1.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$141.2M

Loss-making

Shares outstanding

213,929,572

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #123Korsana BiosciencesKRSA$1.38B
  2. #124InnovivaINVA$1.37B
  3. #125Structure TherapeuticsGPCR$1.35B
  4. #126Damora TherapeuticsDMRA$1.35B
  5. #127Mineralys TherapeuticsMLYS$1.35B

What if Structure Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$395,974.34

Per share 20,841× higher

Bitcoin $1.53T

$21,425.48

Per share 1,128× higher

Apple $5.02T

$70,337.86

Per share 3,702× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Structure Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.